Help with covering the costs of Amgen medicines, including KYPROLIS® (carfilzomib).
Expanded access program (EAP) for belantamab mafodotin, an investigational immunoconjugate against B-cell maturation antigen (anti-BCMA) being evaluated in several studies as a treatment for multiple myeloma. The EAP is available to eligible multiple myeloma patients in the U.S. who have undergone stem cell transplant or are considered transplant ineligible and are refractory to previous treatment with a proteasome inhibitor, immunomodulatory drug, and anti-CD38 therapy.
Help for individuals who cannot afford insurance co-pays for medications to treat cancer.
Help with navigating the challenges of reimbursement, co-pay assistance, and questions about obtaining Bristol-Myers Squibb (BMS) products REVLIMID® (lenalidomide), POMALYST® (pomalidomide), and THALOMID® (thalidomide).
Information on all Medicare and Medicaid services and programs, including The Affordable Care Act. It is illegal for a plan to deny coverage because a person is sick. Lower costs for prescription drugs in the "donut hole."
Reimbursement support, insurance coverage verification, and product-specific claims and appeals for DARZALEX®(daratumumab). Referrals to independent foundations that may have available funding to help minimize drug costs.
Reimbursement support, insurance coverage verification, and product-specific claims and appeals for DOXIL®(doxorubicin HCl liposome injection). Referrals to independent foundations that may have available funding to help minimize drug costs.
Assistance with co-payment or co-insurance requirements for eligible, commercially insured patients who have been prescribed Bristol-Myers Squibb oncology products, including EMPLICITI® (elotuzumab).
Co-pay support for FARYDAK® (panobinistat) by Secura Bio.
Financial Support for patients in need. Mission is to ensure no one has to choose between getting the medication they need and affording the necessities of everyday living.
Information on risk pools for the medically uninsurable, with a listing by state and how to contact them.
Financial assistance for eligible individuals to cover co-insurance, co-payments, healthcare premiums and deductibles for certain medications and therapies.
Helps pay insurance premiums and meet co-pay obligations, plus helps find additional sources of financial help.
Helps qualifying patients without prescription drug coverage get the medicines they need.
Information on programs that help people facing problems paying for medications and healthcare, and assistance with applying to programs.
Assistance with costs and other day-to-day needs associated with NINLARO® (ixazomib) treatment.
Provides assistance to underinsured patients for their out-of-pocket expenses for life-saving medications.
Co-pay assistance for pharmaceutical products to qualified insured patients, including Medicare Part D beneficiaries.
Reimbursement support, insurance coverage verification, and product-specific claims and appeals for PROCRIT®(epoetin alfa). Referrals to independent foundations that may have available funding to help minimize drug costs.
A database of patient assistance programs run by pharmaceutical companies, as well as practical tools, news, and articles.
Helping eligible patients with access and support for the treatment they’ve been prescribed.
Helps qualifying uninsured patients access Amgen medicines at no cost.
A comprehensive program committed to helping patients taking Takeda Oncology medicines navigate coverage requirements, identify available financial assistance and connect with helpful resources throughout their treatment. The Takeda Oncology Here2Assist™ Patient Support Program is ready to support the needs of patients. Any customer questions should be directed to Takeda Oncology at 1-844-817-6468, Option 2.
Takeda's program for patients, physicians, and caregivers to provide reimbursement assistance related to the use of VELCADE® (bortezomib).
The KaryForward patient support program by Karyopharm has Copay and Patient Assistance programs which can help you with the cost of and access to Xpovio.